pGADT7-AP-1 σ1B
(Plasmid
#198335)
-
PurposeExpression of GAL4 transcriptional activation domain (AD)-AP-1 σ1B fusion protein in yeast (yeast two-hybrid assays)
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 198335 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepGADT7
- Backbone size w/o insert (bp) 7987
- Total vector size (bp) 8424
-
Vector typeYeast Expression
-
Selectable markersLEU2
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameAP-1 σ1B
-
SpeciesH. sapiens (human)
-
Insert Size (bp)471
-
MutationExpresses a LELQMNRRY nonapeptide after the last residue of AP-1 σ1B
- Promoter ADH1
-
Tags
/ Fusion Proteins
- GAL4 transcriptional activation domain (AD) fragment (N terminal on backbone)
- HA tag (N terminal on backbone)
- LELQMNRRY nonapeptide (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site EcoRI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer GAL4 transcriptional activation domain forward
- 3′ sequencing primer GAL4 transcriptional activation domain reverse (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pGADT7-AP-1 σ1B was a gift from Juan Bonifacino (Addgene plasmid # 198335 ; http://n2t.net/addgene:198335 ; RRID:Addgene_198335) -
For your References section:
The adaptor protein chaperone AAGAB stabilizes AP-4 complex subunits. Mattera R, De Pace R, Bonifacino JS. Mol Biol Cell. 2022 Oct 1;33(12):ar109. doi: 10.1091/mbc.E22-05-0177. Epub 2022 Aug 17. 10.1091/mbc.E22-05-0177 PubMed 35976721